Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 04, 2024 08:00 ET | Source: Alimera Sciences, Inc.

Alimera Completes Recruitment for the Synchronicity Study

ATLANTA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners...
May 18, 2023 07:00 ET | Source: Alimera Sciences, Inc.

Alimera Acquires U.S. Commercial Rights to YUTIQ®

Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023 Alimera projects at least $100 million of consolidated net revenue and over $20 million of Adjusted EBITDA* in 2024...